Trevi Therapeutics (TRVI) Q4 2022 Earnings

16MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.29
-0.21
-0.14
-0.06

Details

Expected EPS
-0.1
Actual EPS
-0.06
Surprise EPS
0.04
Surprise Percent
+40%

Description

Trevi Therapeutics (TRVI) has reported earnings of -0.06 per share for Q4 2022.

0 Comments

Share your thoughts